How Severe Is Chronic Hepatitis with HCV Genotype 1b? A Study of 1,220 Cases on the Waiting List for Antiviral Therapy in Romania (vol 20, pg 51, 2011)

被引:0
|
作者
Pascu, O.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 44 条
  • [1] How Severe Is Chronic Hepatitis with HCV Genotype 1b? A Study of 1,220 Cases on the Waiting List for Antiviral Therapy in Romania
    Pascu, Oliviu
    Gheorghe, Liana
    Voiculescu, Mihai
    Ceausu, Emanoil
    Mateescu, Bogdan
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2011, 20 (01) : 51 - 55
  • [2] Hepatitis C virus (HCV) genotype 2a has a better virologic response to antiviral therapy than HCV genotype 1b
    Wang, Meng
    Zhang, Yi
    Li, Zhiqin
    Zhang, Hongyu
    Zhang, Zhen
    Yue, Dongli
    Zhou, Rong
    Li, Xiaogang
    Wu, Shuhuan
    Li, Jiansheng
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 7446 - 7456
  • [3] Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load
    Arase, Y
    Ikeda, K
    Tsubota, A
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Kobayashi, M
    Suzuki, F
    Akuta, N
    Someya, T
    Kumada, H
    [J]. JOURNAL OF GASTROENTEROLOGY, 2003, 38 (02) : 158 - 163
  • [4] Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load
    Yasuji Arase
    Kenji Ikeda
    Akihito Tsubota
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Masahiro Kobayashi
    Mariko Kobayashi
    Fumitaka Suzuki
    Norio Akuta
    Takashi Someya
    Hiromitsu Kumada
    [J]. Journal of Gastroenterology, 2003, 38 : 158 - 163
  • [5] Effect and safety of daclatasvir and asunaprevir combination therapy for chronic hepatitis HCV genotype 1b infection in patients with severe fibrosis; From real world data
    Ishigami, Masatoshi
    Hayashi, Kazuhiko
    Honda, Takashi
    Kuzuya, Teiji
    Ishizu, Yoji
    Hirooka, Yoshiki
    Goto, Hidemi
    [J]. HEPATOLOGY, 2016, 64 : 965A - 966A
  • [6] Preliminary study of combination therapy with interferon-α and zinc in chronic hepatitis C patients with genotype 1b
    Takeaki Nagamine
    Hitoshi Takagi
    Hisashi Takayama
    Akira Kojima
    Satoru Kakizaki
    Masatomo Mori
    Katuyuki Nakajima
    [J]. Biological Trace Element Research, 2000, 75 : 53 - 63
  • [7] Preliminary study of combination therapy with interferon-α and zinc in chronic hepatitis C patients with genotype 1b
    Nagamine, T
    Takagi, H
    Takayama, H
    Kojima, A
    Kakizaki, S
    Mori, M
    Nakajima, K
    [J]. BIOLOGICAL TRACE ELEMENT RESEARCH, 2000, 75 (1-3) : 53 - 63
  • [8] Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b
    Atsukawa, Masanori
    Tsubota, Akihito
    Kondo, Chisa
    Itokawa, Norio
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Hashimoto, Satomi
    Fukuda, Takeshi
    Matsushita, Yoko
    Kidokoro, Hideko
    Kobayashi, Tamaki
    Kanazawa, Hidenori
    Sakamoto, Choitsu
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) : 51 - 56
  • [9] Fluvastatin does not exhibit antiviral effect on PEG-IFN/Ribavirin/Telaprevir therapy for genotype 1b chronic hepatitis C
    Itokawa, Norio
    Atsukawa, Masanori
    Shimada, Noritomo
    Nakagawa, Ai
    Kondo, Chisa
    Matsushita, Yoko
    Fukuda, Takeshi
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Iwakiri, Katsuhiko
    Sakamoto, Choitsu
    [J]. HEPATOLOGY, 2013, 58 : 1119A - 1119A
  • [10] COMBINATION OF FLUVASTATIN WITH PEGYLATED INTERFERON/RIBAVIRIN THERAPY REDUCES THE VIRAL RELAPSE RATE IN CHRONIC HEPATITIS C INFECTED WITH HCV GENOTYPE 1B
    Atsukawa, M.
    Tsubota, A.
    Kondo, C.
    Itokawa, N.
    Hashimoto, S.
    Fukuda, T.
    Matsushita, Y.
    Kidokoro, H.
    Kobayashi, T.
    Narahara, Y.
    Nakatsuka, K.
    Kanazawa, H.
    Sakamoto, C.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S428 - S428